BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24821088)

  • 21. Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype.
    Cohen CM; Wentzensen N; Castle PE; Schiffman M; Zuna R; Arend RC; Clarke MA
    J Clin Oncol; 2023 Feb; 41(5):1059-1068. PubMed ID: 36455190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher prevalence of hysterectomy among rural women than urban women: Implications for measures of disparities in uterine and cervical cancers.
    Adam EE; White MC; Saraiya M
    J Rural Health; 2022 Mar; 38(2):416-419. PubMed ID: 34081371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of cervical cancer in the United States, 1998-2003.
    Watson M; Saraiya M; Benard V; Coughlin SS; Flowers L; Cokkinides V; Schwenn M; Huang Y; Giuliano A
    Cancer; 2008 Nov; 113(10 Suppl):2855-64. PubMed ID: 18980204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009.
    Simard EP; Naishadham D; Saslow D; Jemal A
    Gynecol Oncol; 2012 Dec; 127(3):611-5. PubMed ID: 22922530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000-2019.
    Amboree TL; Damgacioglu H; Sonawane K; Adsul P; Montealegre JR; Deshmukh AA
    Int J Cancer; 2024 May; 154(9):1549-1555. PubMed ID: 38270521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates.
    Adam EE; White MC; Saraiya M
    Cancer Causes Control; 2022 Jan; 33(1):161-166. PubMed ID: 34546462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk-adjusted cancer-incidence rates (United States).
    Merrill RM; Feuer EJ
    Cancer Causes Control; 1996 Sep; 7(5):544-52. PubMed ID: 8877053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002.
    Saraiya M; Ahmed F; Krishnan S; Richards TB; Unger ER; Lawson HW
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):360-70. PubMed ID: 17267837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
    Henley SJ; King JB; German RR; Richardson LC; Plescia M;
    MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.
    Spencer JC; Burger EA; Campos NG; Regan MC; Sy S; Kim JJ
    J Natl Cancer Inst Monogr; 2023 Nov; 2023(62):188-195. PubMed ID: 37947333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in hysterectomy prevalence and trends among U.S. States and Territories-Behavioral Risk Factor Surveillance System, 2012-2020.
    Gopalani SV; Dasari SR; Adam EE; Thompson TD; White MC; Saraiya M
    Cancer Causes Control; 2023 Oct; 34(10):829-835. PubMed ID: 37329443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
    J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003.
    McDougall JA; Madeleine MM; Daling JR; Li CI
    Cancer Causes Control; 2007 Dec; 18(10):1175-86. PubMed ID: 17805982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy.
    Merrill RM; Layman AB; Oderda G; Asche C
    Ann Epidemiol; 2008 Mar; 18(3):253-60. PubMed ID: 18280923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence-corrected prostate cancer incidence rates and trends.
    Merrill RM; Morris MK
    Am J Epidemiol; 2002 Jan; 155(2):148-52. PubMed ID: 11790678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales.
    Redburn JC; Murphy MF
    BJOG; 2001 Apr; 108(4):388-95. PubMed ID: 11305546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two methods based on cross-sectional data for correcting corpus uterine cancer incidence and probabilities.
    Merrill RM; Lyon JL; Wiggins C
    BMC Cancer; 2001; 1():13. PubMed ID: 11686855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical Cancer Among Older Women: Analyses of Surveillance, Epidemiology and End Results Program Data.
    Quick AM; Krok-Schoen JL; Stephens JA; Fisher JL
    Cancer Control; 2020; 27(1):1073274820979590. PubMed ID: 33291971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data.
    Patel DA; Barnholtz-Sloan JS; Patel MK; Malone JM; Chuba PJ; Schwartz K
    Gynecol Oncol; 2005 May; 97(2):550-8. PubMed ID: 15863159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.